Skip to main content
Vita 34 AG logo

Vita 34 AG — Investor Relations & Filings

Ticker · V3V ISIN · DE000A0BL849 LEI · 529900OEWA4GSZEZ4P40 F Human health and social work activities
Open in API
Filings indexed 794 across all filing types
Latest filing 2012-01-06 Declaration of Voting R…
Country DE Germany
Listing F V3V

About Vita 34 AG

https://www.vita34.de/en/

Vita 34 AG is a biobank specializing in the cryopreservation of stem cells derived from umbilical cord blood and tissue. Established in 1997 as the first private cord blood bank in Europe, the company offers services for the long-term storage of perinatal stem cells for potential future medical applications. The service portfolio includes providing collection kits for childbirth, handling logistics, processing the biological material, and storing the stem cell deposits under cryogenic conditions. These services are offered to expectant parents as a form of private medical provision for their child and family. As part of the Famicord Group, Vita 34 is also involved in research and development related to cell-based therapies.

Recent filings

Filing Released Lang Actions
Declaration of Voting Results & Voting Rights Announcements 2012
Declaration of Voting Results & Voting Rights Announcements Classification · 100% confidence The document is explicitly titled 'Voting Rights Announcements' and details a notification regarding changes in share percentage thresholds being exceeded, referencing German Securities Trading Act (§ 26 WpHG). This directly corresponds to the definition of 'Declaration of Voting Results & Voting Rights Announcements' (DVA), which covers official results from shareholder votes or, as in this case, significant changes in voting rights/shareholdings reported to the market.
2012-01-06 English
Jahresabschluss zum Geschäftsjahr vom 01.01.2009 bis zum 31.12.2009
Audit Report / Information Classification · 95% confidence The document is a 'Bericht des Aufsichtsrates' (Supervisory Board Report) for VITA 34 AG for the fiscal year 2009. It details the board's oversight activities, the appointment of the auditor (Ernst & Young AG), and the approval of the annual financial statements. This is a standalone audit-related governance document, which fits the 'Audit Report / Information' (AR) category. FY 2009
2011-12-08 German
Audit Report / Information 2011
Audit Report / Information Classification · 95% confidence The document is titled "AKTIONÄRSBRIEF 2/2011" (Shareholder Letter 2/2011) and contains a mix of operational updates (transplantations, research projects), market surveys, partnership announcements (Spanish clinic chain), legal commentary (ECJ ruling), corporate structure changes (merger), and detailed financial results for the 3rd Quarter of 2011, including a comparison table and an outlook for the rest of the year. The text explicitly mentions that the "Vollständige Quartalsbericht steht im Internet unter www.vita34group.de zum Download bereit" (The complete quarterly report is available for download on the internet at www.vita34group.de). This structure—a summary letter covering operational highlights, research, and key financial figures for a specific period (Q3 2011), while referencing the full report elsewhere—is characteristic of an Interim/Quarterly Report (IR) or a Management Discussion & Analysis (MDA) that often accompanies it. Given the depth of the financial data presented (Umsatz, EBITDA, Konzernergebnis for Q3 2011) and the focus on a specific reporting period shorter than a year, the most appropriate classification is Interim / Quarterly Report (IR). It is more comprehensive than a simple Earnings Release (ER) but less formal than a full 10-K. Q3 2011
2011-12-05 English
Fund Information / Factsheet 2011
Fund Information / Factsheet Classification · 99% confidence The document is titled "AKTIONÄRSBRIEF 2/2011" (Shareholder Letter 2/2011) and contains a mix of operational updates (transplantations, research projects), market surveys, partnership announcements (Spanish clinic chain), legal commentary (ECJ ruling), corporate structure changes (merger), and detailed financial results for the 3rd Quarter of 2011, including a comparison table and an outlook for the rest of the year. The text explicitly mentions that the "Vollständige Quartalsbericht steht im Internet unter www.vita34group.de zum Download bereit" (The complete quarterly report is available for download on the internet at www.vita34group.de). This structure—a summary letter covering operational highlights, research, and key financial figures for a specific period (Q3 2011), while referencing the full report elsewhere—is characteristic of an Interim/Quarterly Report (IR) or a Management Discussion & Analysis (MDA) that often accompanies it. Given the depth of the financial data presented (Umsatz, EBITDA, Konzernergebnis for Q3 2011) and the focus on a specific reporting period shorter than a year, the most appropriate classification is Interim / Quarterly Report (IR). It is more comprehensive than a simple Earnings Release (ER) but less formal than a full 10-K.
2011-12-05 German
Declaration of Voting Results & Voting Rights Announcements 2011
Declaration of Voting Results & Voting Rights Announcements Classification · 100% confidence The document explicitly states 'Voting Rights Announcements' in the title and details a notification from Mr. Dr. Holger Födisch regarding his share percentage crossing the 3% threshold, citing Article 26, Section 1 of the WpHG (§ 21 section 1 WpHG). This directly corresponds to the definition of 'Declaration of Voting Results & Voting Rights Announcements' (Code: DVA), which covers notifications about changes in significant share ownership thresholds.
2011-12-02 English
DGAP-DD: VITA 34 AG english
Director's Dealing Classification · 100% confidence The document is explicitly titled 'Directors’ Dealings' and contains a 'Notification concerning transactions by persons performing managerial responsibilities pursuant to section 15a of the WpHG'. It details a purchase of shares by 'Dr. Holger Födisch', identified as a 'Member of an administrative or supervisory body' (i.e., a director/executive). This directly matches the definition for Director's Dealing.
2011-11-29 English

Browse filings by year

20 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.